Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Rein Therapeutics Receives FDA Clearance to Resume U.S. Phase 2 Trial of LTI-03 in Idiopathic Pulmonary Fibrosis
-
Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
-
Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer
-
Kailera Therapeutics Appoints Frank Clyburn to Board of Directors
-
Apogee Therapeutics to Participate in Upcoming Conferences
-
DeFi Crypto Mutuum Finance (MUTM) Details V1 Launch Roadmap as Phase 6 Nears 90% Allocation
-
NIP Group Expands Bitcoin Mining Capacity with Additional Asset-Purchase Agreement
-
Genie Energy Announces Third Quarter 2025 Results
-
Digi Power X Strengthens Balance Sheet to Support 2026 AI Infrastructure Development Plan
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
-
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
-
Osisko Development Strengthens Technical Team With Appointment of Vice President, Exploration
-
Phoenix Asia Holdings Limited Announces Addition to Board of Directors
-
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
-
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
-
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
-
Nexxen Announces October 2025 Share Repurchase Program Summary
-
HSBC Continental Europe: Pre Stabilisation Notice
-
Willis Lease Finance Corporation Announces New Revolving Credit Facility for Joint Venture, Willis Mitsui & Co. Engine Support Limited
-
Willis Lease Finance Corporation Announces New Revolving Credit Facility for Joint Venture, Willis Mitsui & Co. Engine Support Limited
-
Bombardier Announces Notice of Redemption for All of its 7.875% Senior Notes due 2027
-
MGA’s Miniverse™ Brings Minecraft™ to Life in Miniature with New Make It Mini™ Collection
-
Cipher Mining Provides Third Quarter 2025 Business Update
-
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
-
Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
-
Kraig Biocraft Laboratories Confirms Spider Silk Production Operations Unaffected by Southeast Asia Typhoons due to Strategic Relocations to Highland Over Last 24 Months
-
Vertex Announces Third Quarter 2025 Financial Results and $150 Million Class A Common Stock Repurchase Program
-
New Report Reveals Disconnect Between Short-Term Focus and Long-Term, Data-Backed Growth Strategies for Health Systems
-
Mason Law Provides Corporate Update
-
MacroMT Unveils Corporate Vision Blueprint, Defining Mission and Core Values for the New Era of Fintech
-
Foodservice sector added nearly 24,000 jobs since start of the year, but inflation and affordability continue to squeeze profit margins
-
Canterra Minerals Announces Commencement of Drilling on the Wilding Gold Project, Newfoundland
-
MAX Power More Than Doubles Length of Genesis Trend to 475 km
-
Lightbridge Receives Notice of Allowance on New Patent from the Eurasian Patent Office
-
Empowering Positive Community Impact Through Hockey, Dr. Oetker’s Giuseppe Pizzeria “Practice with a Pro” Contest Returns for the Fourth Year
-
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
-
TopBuild Announces Specialty Distribution and Installation Services Acquisitions
-
Rêve Diamonds Reveals 19% Drop in U.S. Engagement Ring Spend as Custom and Lab-Grown Styles Rise
-
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
-
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
-
Kashable Joins Forces with Brooklyn Football Club to Empower Women in Sports
-
EyePoint Announces Participation at Upcoming Investor Conferences
-
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
-
BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Tisento Therapeutics Announces Publication of MELAS Interview Study, Incorporating Patients’ Perspectives to Elucidate Symptoms and Impacts of Rare Mitochondrial Disease
-
mimic robotics raises $16 million to deploy frontier physical AI across industries
-
Jade Biosciences to Participate in Upcoming Conferences
